Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,073 public trials 1,365 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Active, Not Recruiting

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

NCT05945823

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +22 more
Locations
  • University of California Los Angeles UCLA - Cancer Care - Santa Monica Santa Monica, California, United States
  • Rocky Mountain Cancer Centers Midtown Denver, Colorado, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

NCT03772028

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • MSKCC New York New York, United States
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • CHU de Besancon Besançon, France
View all 28 locations
View Trial Details
Active, Not Recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

NCT03937154

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • Saint Bernards Medical Center Jonesboro, Arkansas, United States
  • Los Angeles Cancer Network Anaheim, California, United States
  • University of California Irvine Orange, California, United States
  • Colorado West Healthcare System dba Grand Valley Oncology Grand Junction, Colorado, United States
View all 139 locations
View Trial Details
Active, Not Recruiting

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

NCT04938583

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Korea Anam Hospital Seoul, South Korea
  • Asan Medical Hospital Seoul, South Korea
  • Seoul St. Mary's Hospital Seoul, South Korea
  • Kyungpook National University Chilgok Hospital Daegu, South Korea
View Trial Details
Active, Not Recruiting

9-ING-41 in Patients With Advanced Cancers

NCT03678883

Conditions
Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California Irvine Health Orange, California, United States
View all 66 locations
View Trial Details

Related conditions